Tracking Molecular Shifts in High-Risk Luminal Breast Cancer: Insights from the Penelope-B Trial
Published on February 10, 2025, in Cancer Cell, this international effort led by Carsten Denkert and colleagues investigates the dynamics of therapy-induced molecular heterogeneity in high-risk HR+/HER2− breast cancer, using…









